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INTRODUCTION
Hutchinson-Gilford progeria syndrome (HGPS) and
Werner’s syndrome are two well-characterized disorders
that present with most of the features of premature aging.
HGPS is a recent member of the family of “laminopathies”,
and these are caused by mutations in LMNA which are
inherited either autosomal dominant (AD) or autosomal
recessive (AR) manner. Most HGPS probands are hetero-
zygous for LMNA G608G, but one atypical HGPS
proband was found to have an E145K mutation and one
recently reported patient was a compound heterozygote for
R471C and R527C mutations. Furthermore, a small subset
of patients with the features of the adult-onset premature
aging Werner’s syndrome (WRN, OMIM 277700), but
without mutations in the causative WRN/RECQL2 gene
was found to have novel heterozygous LMNA mutations
[1]. Werner’s syndrome is an autosomal recessive disorder
and this is caused by the Werner syndrome gene (WRN),
which encodes a RecQ-type DNA/RNA helicase [2]. The
gene is located on the 8p11-12 locus and it encodes a 1432
amino acid protein (WRN) that’s homologous to the RecQ
subfamily helicases [1]. 
Children with HGPS usually appear normal at birth, but
they experience profound failure to thrive during the first
year. Characteristic facies, alopecia, lose of subcutaneous
fat, stiffness of joints, bone changes and abnormal
tightness of the skin over the abdomen and upper thighs
usually become apparent during the second or third year
[3]. On the other hand, patients with Werner’s syndrome
have a bird-like appearance of the face [4]. The clinical
manifestations of Werner’s syndrome occur during the
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CASE REPORT
Hutchinson-Gilford progeria syndrome (HGPS) and Werner’s syndrome are representative types of progeroid
syndrome. LMNA (Lamin A/C) gene mutation with atypical Werner’s syndrome have recently been reported.
Atypical Werner’s syndrome with the severe metabolic complications, the extent of the lipodystrophy is
associated with A133L mutation in the LMNA gene and these patients present with phenotypically
heterogeneous disorders. We experienced a 15-yr-old Korean female with progeroid features, generalized
lipodystrophy, hypertriglyceridemia, fatty liver, steatohepatitis, and type 2 diabetes mellitus. Skin fibroblasts from
the patient showed marked abnormal nuclear morphology, compared with that from normal persons. Gene
analysis revealed that this patient had T506del of exon 2 in the LMNA gene. We report here the first case of atypical
Werner’s syndrome with frameshift mutation that was caused by T506del. (Korean J Intern Med 2009;24:68-72)
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(MKE).third or fourth decade, and these patients die prematurely
during the fourth or fifth decade [4,5]. HGPS is a rare,
autosomal dominant disorder and it is caused by specific
synonymous heterozygous de novo mutations that affect
the codon 608 of the LMNA gene, which normally
encodes for a glycine residue [6-9]. These mutations
generate an alternative splicing site in exon 11, resulting in
a truncated lamin A protein. 
The other form of progeroid syndrome, atypical
Werner’s syndrome, was first reported on in 2003 by
Lishan Chen, etc [10]. These patients have heterozygous
missense mutations in the LMNA gene, which were
distinct from those reported in patients with typical
HGPS. We found atypical Werner’s syndrome in a 15-yr-
old woman with lipodystrophy, steatohepatitis, type 2
diabetes mellitus and progeroid features, and the patient
had T156del in the LMNA gene.
CASE REPORT
Clinical and laboratory history
A 15-yr-old woman presented with abdominal dis-
tension and an elevated blood glucose level. She was born
at full term with a birth weight of 2.7 kg by c-section
delivery. Hyperpigmentation of her skin developed 10
months from birth. She attained menarche at the age of 13
yr, and this was followed by an irregular period. She
developed diabetes mellitus at the age of 13 yr and began
diabetic treatment with oral hyperglycemic agents
(sulfonylurea, metformin, voglibose). Yet she didn’t achieve
good glycemic control despite using oral hypoglycemic
agents. On admission, her random plasma glucose was
measured by the glucose oxidase method using a Hitachi
Modular D2400 (Roche, Tokyo, Japan) and the serum
cholesterol, triglycerides, high-density lipoprotein
cholesterol and chemistry were tested using a Hitachi
Modular D2400 (Roche, Tokyo, Japan). Her fasting
plasma glucose (13.2 mmol/liter), triglyceride (14.9
mmol/liter), alanine aminotransferase (87 U/L), and
aspartate aminotransferase levels (70 U/L) were all
increased. She had severe hepatomegaly on the MR
imaging. Microvesicular and macrovesicular changes and
perivenular fibrosis were noted on the liver biopsy. On
examination, she looked older than her age group and she
had the bird-like face with a beaked nose (Fig. 1A and 1B).
The skin over the hands and feet was atrophic with
prominent superficial veins (Fig. 1C). She had thin, spindle-
shaped fingers with mild flexion contractures of the distal
and proximal interphalangeal joints and elbow joints (Fig.
1C). She had a small mandible and a small mouth (Fig.
1B). There was hyperpigmented skin covering the neck,
trunk and upper extremities (Fig. 1D). She had gener-
alized loss of subcutaneous fat over the face, neck, upper
chest area, hips, and extremities (Fig. 1A and 1C). The
lateral quadriceps were prominent bilaterally. There was
no graying, but there was thinning of scalp hair and
diminution of hair over her eyebrows and over her upper
and lower extremities. The liver was palpable 5 cm below
the right costal margin, and the spleen was not palpable.
She didn’t have cataract or any abnormality in fundus
exam. Doppler echocardiography did not show concentric
left ventricular hypertrophy, increased left ventricular
pressures, aortic or mitral regurgitation, or calcification of
the posterior annulus. The whole-body fat and regional fat
in the head, trunk and upper and lower extremities were
determined by performing dual-energy X-ray absorp-
tiometry (DEXA) scanning (GE Lunar [Madison, WI]
instruments). The proportion of fat in the individual
lesions as well as that of the whole body was calculated as
a percentage of the body mass. She had markedly reduced
body fat with generalized lipodystrophy. The body fat with
using DEXA was estimated to be 6.5% of the total body
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Figure 1. Anterior view and the face of the patient are shown in A
and B. The patient looks older than her chronological age. Note the
beaked nose, marked lipodystrophy and thin lips with deep
furrows. C and D. Close-up of her hand and her axillary region,
respectively. Note the loss of fat and the atrophic-appearing skin
over the hand and foot. The axillary region shows a lack of hair and
mottled skin pigmentation, but no acanthosis nigricans. 
A
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Bmass. Whole body MRI studies confirmed markedly
decreased subcutaneous fat, abdominal fat and intratho-
racic fat (Fig. 2). MRI studies were performed using a 3
Tesla imaging device (GE Signa Exite 3.0 HD T) at the
trunk (chest, abdomen) and the peripheral (biceps,
triceps, forearm, thigh, and calf) limbs. Her grandmother
was diagnosed with diabetes mellitus at 72 yr old, but her
parents, brother and sister did not have any history of
diabetes or cardiovascular disease. Her parents, brother,
and younger sister didn’t have an abnormal appearance
of their faces, extremities, skin and etc. We did not find
abnormal finding in their medical histories.
Lamin A/C immunofluorescence in skin fibroblasts
Primary fibroblasts from skin biopsy samples were
grown on Dulbecco’s modified Eagle’s medium (DMEM,
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Figure 2. Midline sagittal T1-weighted MRI at the level of the head and chest region, and the transaxial MRI at the level of the abdomen (A).
Note the near total loss of subcutaneous truncal and neck fat in the patient. The abdominal MRIs show decreased intraabdominal fat,
compared with a normal subject (B). T1-weighted transaxial MRI at the level of the distal leg and thigh, and a sagittal MRI of the distal leg, foot
and thigh from the patient (C and D, respectively). Note the loss of subcutaneous fat in the calves, dorsum and plantar aspects of the feet.
Sections through the thigh reveal decreased intermuscular fat in a patient, compared with the normal control.
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Figure 3. Indirect immunofluorescence microscopy using lamin A/C antibody reaction in the skin fibroblasts obtained from a control subject
(Normal), and the patient. Panels i, ii, iii and vi show immunostaining for lamin A/C; panels iv and vii show nuclear DNA staining; panels v and viii
show the merged images from the lamin A/C and DNA staining. Multilobulated nuclei were observed more frequently in the patient. Panels ix, x, xi
and xii also show several individual nuclei from the patient, and the nuclei were stained for lamin A/C protein; they displayed various deformities
(xi, xii).
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vii viiiGibco Lab, NY, USA) and they were fixed in phosphate
buffered saline (PBS) that contained 4% formaldehyde for
30 minutes at 4˚C . The cells were made permeable by
incubating them in 0.1% Triton X-100 for 15 min at room
temperature and then they were blocked for nonspecific
binding by incubation with monoclonal anti-lamin
antibody (antibody H-110 at a 1:100 dilution in blocking
buffer; Santa Cruz Biotechnology, Santa Cruz, CA.) for 60
min at 37˚C . The primary antibody was removed, and the
coverslip was washed with PBS and then incubated with
the secondary antibody conjugated with FITC-conjugated
goat anti-rabbit IgG antibody for 120 min at room
temperature. After washing, the coverslips were mounted
using commercial mounting medium for fluorescent
microscopy (Aqua Poly/ Mount; Polysciences, Inc.,
Warrington, PA.), and the slides were examined using an
AxioCam MRc5 microscope (Carl Zeiss USA, Thornwood,
NY). The skin fibroblasts from this patient were from the
7th passage. Indirect immunofluorescent studies revealed
normal localization of the lamin A/C protein in the nuclear
envelope in the affected subject. The captured images of
the nuclei showed abnormal nuclear morphology. Several
deformed nuclei, multilobulations, nuclear membrane
invagination and nuclear hypertrophy were observed in
this patient (Fig. 3).
Exon 2 sequence of the LMNA DNA
We found the exonic sequence associated with the
T506del and it was 25.374 Kb of genomic DNA. The
nucleotide numbering started with the adenine of the first
ATG codon for lamin A/C. We found a T deletion in exon
2 in the LMNA gene that resulted in altered amino acid
sequence from codon 169 to stop codon (Fig. 4). Although
G507del was found in LMNA gene of her mother and
sister, they didn’t have any phenotype of premature aging
or lipodystrophy. The exonic sequence of the LNMA gene
of her father and brother had the same sequence
compared with other normal persons. The exonic
sequence of the LMNA gene of each person is shown in
Figure 4.
DISCUSSION
Progeroid syndrome is a rare disorder that is caused by
gene mutation. Progeroid syndrome is divided into 5
subtypes by the mutation site of the gene and the pheno-
types [1]. The common types among them are HGPS and
Werner’s syndrome. Atypical Werner’s syndrome was
recently reported on [6,10]. The patients with atypical
Werner’s syndrome have some different phenotypes
compared to the phenotypes of patients with Werner’s
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Figure 4. Sequence of the chromatin of the patient and her family. This shows the T506 deletion of
the nucleotide in exon 2 of the LMNA gene, resulting in frameshift mutation and premature stop
codon in the patient. G507 deletion of her mother and sister also induced frameshift mutation but
showed normal phenotype.
Exon 2 ; T506del
Normal control :  GTG  GCC  AAG  CTT  GAG  GCA  GCC  CTA  GGT
 Val  Ala  Lys  Leu  Glu  Ala  Ala  Leu  Gly
Patient :  GGG  CCA  AGC  TTG  AGG  CAG  CCC  TAG  GT
 Gly  Pro  Ser  Leu  Arg  Gln  Pro  stop
Patient's mother : GTG  CCA  AGC  TTG  AGG  CAG  CCC  TAG  GT
 Val  Pro  Ser  Leu  Arg  Gln  Pro  stop
Patient's sister :  GTG  CCA  AGC  TTG  AGG  CAG  CCC  TAG  GT
 Val  Pro  Ser  Leu  Arg  Gln  Pro  stop
(T506del)
Codon 169
(G507del)
(G507del)syndrome.
For the atypical Werner’s syndrome that was reported
in 2003 by Lishan Chen, the patients had heterozygous
R133L, L140R and A57P LMNA mutations [10]. In 2005,
two patients were evaluated at the General Clinical
Research Center of the University of Texas Southwestern
Medical Center at Dallas. It was detected that the patients
had A133L due to being heterozygous for the 398G>T
LMNA mutation [6]. Phenotypic variation has been
observed in other patients that suffer from laminopathies
[6,11,12]. The patients with atypical Werner’s syndrome
have mutation of the LMNA gene that codes for the
intermediate filament lamin, and so they have various
phenotypes such as myopathy, lipodystrophy, mandibu-
loacral malformation and etc. 
The hypotheses about how LMNA gene mutation induces
the disease include alteration of nuclear structure, cell
instability and tissue atrophy [10,13]. For the second
hypothesis, the intermediate filament lamin acts to
regulate several important nuclear components whose
activities are important to prevent disease onset [10,14].
Yet there is no information about the pathophysiology of
tissue specificity [10].
A hypothesis on how the progeroid features in atypical
Werner’s syndrome develop has been suggested. The
hypothesis was that abnormal function of retinoblastoma
protein may be associated with the progeroid phenotypes
[10]. In this case, we didn’t check if she had abnormal
function of retinoblastoma protein, but we observed the
abnormal shapes of the fibroblast nuclei.
T506del in LMNA has not been previously reported on in
a patient with atypical Werner’s syndrome. We found that
this patient had the T506del and the early expression of
the stop codon. We investigated for genetic mutation of
her family members. Her father and younger brother had
normal genetic arrangement compared with the normal
control group. Her mother and younger sister had the
G507del, resulting in a change of amino acid arrangement
compared to normal populations. The amino acid
arrangement of our patient was the same as her mother
and younger sister, except for a valine substitution for
glycine. But her mother and younger sister did not show
abnormal findings in their appearance. The T506del
results in disease, but the G507del didn’t induce abnormal
phenotypes in her mother and sister, despite the
abnormal arrangement in the amino acid. We didn’t
investigate the WRN gene mutation in this patient and her
family members because her external features and clinical
symptoms were similar to those of the reported patients
with atypical Werner’s syndrome [6].
In summary, we found a new patient with atypical
Werner’s syndrome, and this patient had mutation of
the T506del in the LMNA gene. She had characteristic
progeroid features, generalized lipodystrophy, diabetes
mellitus, hypertriglyceridemia and a fatty liver. We found
that the cause of disease was deletion of the LMNA gene.
However, the molecular mechanism of the T506del in the
LMNA gene, and the relationship between the other
mutations in the LMNA gene and the clinical hetero-
geneity both remain to be determined.
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